Successful treatment of a facial attack of angioedema with icatibant in a patient with idiopathic angioedema

被引：15
|
作者：
Montinaro, Vincenzo [1 ,2 ]
Loizzo, Giuliana [1 ,2 ]
Zito, Anna [1 ,2 ]
Castellano, Giuseppe [1 ,2 ]
Gesualdo, Loreto [1 ,2 ]
机构：
[1] Univ Aldo Moro, Azienda Osped Univ Consorziale Policlin, Div Nephrol Transplant & Dialysis, Bari, Italy
[2] Univ Aldo Moro, Azienda Osped Univ Consorziale Policlin, Ctr Diag & Treatment Hereditary Angioedema, Bari, Italy
来源：
AMERICAN JOURNAL OF EMERGENCY MEDICINE | 2013年 / 31卷 / 08期
关键词：
HEREDITARY ANGIOEDEMA; RECEPTOR ANTAGONIST; BRADYKININ;
D O I：
10.1016/j.ajem.2013.04.024
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
Angioedema (AE) is related to the activation of the contact phase system-kallikrein and generation of bradykinin. Different types of AE are recognized: hereditary or acquired deficit of the C1 inhibitor, drug-related, or idiopathic. Treatment of idiopathic nonhistaminergic AE (IAE) is difficult because corticosteroids, antihistamine drugs, and adrenalin are inefficacious. We describe a patient with an IAE and an acute attack of facial AE that was successfully treated with the bradykinin receptor antagonist icatibant. This case report strengthens the relevance of bradykinin formation in IAE and underlines the effectiveness of icatibant as a therapeutic option in acute IAE.
引用
收藏
页码：1295.e5 / 1295.e6
页数：2
相关论文
共 50 条
  • [1] Positive treatment outcome with icatibant in an adolescent patient with acute hereditary angioedema attack
    Bjorkander, J.
    ALLERGY, 2011, 66 : 427 - 427
  • [2] Successful and Safe Use Of Icatibant For Life-Threatening Angioedema Attack During Pregnancy In a Patient With Hereditary Angioedema Type I
    Boufleur, Karine
    Delcaro, Luana
    Cordeiro, Daniel L.
    Botelho Palhas, Priscila B.
    de Melo Sousa, Janaina Fernandes
    Mendonca, Thais
    de Lima Melo, Janaina Michele
    Neppelenbroek, Gustavo
    Sarti, Wlly
    Moreno, Adriana S.
    Arruda, Luisa Karla P.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB36 - AB36
  • [3] Successful treatment with Icatibant in ACE Inhibitor induced angioedema
    Perez, D.
    Marco, G.
    Infante, S.
    Zubeldia, J.
    Rubio, M.
    ALLERGY, 2010, 65 : 611 - 612
  • [4] Successful treatment of idiopathic angioedema with ecallantide
    Berry, Alalia
    Firszt, Rafael
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2013, 1 (03): : 297 - 298
  • [5] Icatibant for the Treatment of Hereditary Angioedema
    Cole, Sabrina W.
    Lundquist, Lisa M.
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (01) : 49 - 55
  • [6] Icatibant for the treatment of hereditary angioedema
    Kalra, Neelu
    Craig, Timothy
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (07): : 743 - 750
  • [7] IDIOPATHIC NONHISTAMINERGIC ANGIOEDEMA TREATED WITH ECALLANTIDE AND ICATIBANT
    Harris, C. K.
    Stahl, M.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2012, 109 (05) : A80 - A80
  • [8] Nonhistaminergic Idiopathic Angioedema: Clinical Response to Icatibant
    Colas, C.
    Montoiro, R.
    Fraj, J.
    Garces, M.
    Cubero, J. L.
    Caballero, T.
    JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2012, 22 (07) : 520 - 521
  • [9] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant
    Weller, K.
    Magerl, M.
    Maurer, M.
    ALLERGY, 2009, 64 : 155 - 156
  • [10] Successful treatment of an acute attack of acquired angioedema with the bradykinin-B2-receptor antagonist icatibant
    Weller, K.
    Magerl, M.
    Maurer, M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (01) : 120 - 120
12345